Elucidating the mechanisms of nickel compound uptake: A review of particulate and nano-nickel endocytosis and toxicity

Toxicology and Applied Pharmacology

Volumn 260, Issue 1, 2012, Pages 1-16

  Muñoz, Alexandra ^a   Costa, Max ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clathrin mediated endocytosis; Endocytosis; Macropinocytosis; Nanoparticles; Nickel; Nickel subsulfide; Nickel sulfide; Phagocytosis; Toxicity

Indexed keywords

CALCIUM; CLATHRIN; DANSYLCADAVERINE; DNA; MANGANESE; NANOPARTICLE; NICKEL; NICKEL SUBSULFIDE; NICKEL SULFATE; NICKEL SULFIDE; P21 ACTIVATED KINASE 1; SULFIDE; UNCLASSIFIED DRUG;

CARCINOGENICITY; CELL MEMBRANE; CELL TRANSFORMATION; CELL TRANSPORT; CELL VACUOLE; CHEMICAL CARCINOGENESIS; CHEMICAL STRUCTURE; COATED VESICLE; CRYSTAL STRUCTURE; CYTOTOXICITY; DISSOLUTION; DNA METHYLATION; ENDOCYTOSIS; ENVIRONMENTAL EXPOSURE; EPIGENETICS; GENE EXPRESSION REGULATION; HUMAN; IN VIVO STUDY; INHALATION; INTOXICATION; LUNG CANCER; LYSOSOME; MOLECULAR INTERACTION; NICKEL TOXICITY; NONHUMAN; NOSE CANCER; OCCUPATIONAL EXPOSURE; OXIDATIVE STRESS; PARTICLE SIZE; PARTICULATE MATTER; PINOCYTOSIS; REVIEW; SURFACE CHARGE;

ANIMALS; CALCIUM; CARCINOGENS; ENDOCYTOSIS; ENVIRONMENTAL POLLUTANTS; HUMANS; NANOPARTICLES; NICKEL; PARTICLE SIZE; SOLUBILITY; SURFACE PROPERTIES; TEMPERATURE;

EID: 84858283556     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.12.014     Document Type: Review

References (120)

1. Abbracchio M.P., Heck J.D., Caprioli R.M., Costa M. Differences in surface-properties of amorphous and crystalline metal sulfides may explain their toxicological potency. Chemosphere 1981, 10:897-908.
2. Abbracchio M.P., Evans R.M., Heck J.D., Cantoni O., Costa M. The regulation of ionic nickel uptake and cyto-toxicity by specific amino-acids and serum components. Biol. Trace Elem. Res. 1982, 4:289-301.
3. Andersen A., Berge S.R., Engeland A., Norseth T. Exposure to nickel compounds and smoking in relation to incidence of lung and nasal cancer among nickel refinery workers. Occup. Environ. Med. 1996, 53:708-713.
4. Arita A., Costa M. Epigenetics in metal carcinogenesis: nickel, arsenic, chromium and cadmium. Metallomics 2009, 1:222-228.
5. Arrouijal F.Z., Hildebrand H.F., Vophi H., Marzin D. Genotoxic activity of nickel subsulphide alpha-ni3s2. Mutagenesis 1990, 5:583-589.
6. Bal W., Karantza V., Moudrianakis E.N., Kasprzak K.S. Interaction of nickel(II) with histones: In vitro binding of nickel(II) to the core histone tetramer. Arch. Biochem. Biophys. 1999, 364:161-166.
7. Bal W., Liang R.T., Lukszo J., Lee S.H., Dizdaroglu M., Kasprzak K.S. Ni(II) specifically cleaves the C-terminal tail of the major variant of histone H2A and forms an oxidative damage mediating complex with the cleaved-off octapeptide. Chem. Res. Toxicol. 2000, 13:616-624.
8. Bartneck M., Keul H.A., Singh S., Czaja K., Bornemann J., Bockstaller M., Moeller M., Zwadlo-Klarwasser G., Groll J. Rapid uptake of gold nanorods by primary human blood phagocytes and immunomodulatory effects of surface chemistry. ACS Nano 2010, 4:3073-3086.
9. Baylin S.B., Herman J.G. DNA hypermethylation in tumorigenesis - epigenetics joins genetics. Trends Genet. 2000, 16:168-174.
10. Bennett B.G. Environmental nickel pathways to man. IARC Sci. Publ. 1984, 487-495.
11. Biggart N.W., Costa M. Assessment of the uptake and mutagenicity of nickel chloride in salmonella tester strains. Mutat. Res. 1986, 175:209-215.
12. Broday L., Peng W., Kuo M.H., Salnikov K., Zoroddu M., Costa M. Nickel compounds are novel inhibitors of histone H4 acetylation. Cancer Res. 2000, 60:238-241.
13. Chen H., Costa M. Iron- and 2-oxoglutarate-dependent Dioxygenases: an emerging group of molecular targets for nickel toxicity and carcinogenicity. Biometals 2009, 22:191-196.
14. Chen H.B., Davidson T., Singleton S., Garrick M.D., Costa M. Nickel decreases cellular iron level and converts cytosolic aconitase to iron-regulatory protein 1 in A549 cells. Toxicol. Appl. Pharmacol. 2005, 206:275-287.
15. Chen H.B., Ke Q.D., Kluz T., Yan Y., Costa M. Nickel ions increase histone H3 lysine 9 dimethylation and induce transgene silencing. Mol. Cell. Biol. 2006, 26:3728-3737.
16. Chen H.B., Giri N.C., Zhang R.H., Yamane K., Zhang Y., Maroney M., Costa M. Nickel ions inhibit histone demethylase JMJD1A and DNA repair enzyme ABH2 by replacing the ferrous iron in the catalytic centers. J. Biol. Chem. 2010, 285:7374-7383.
17. Chithrani B.D., Chan W.C.W. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett. 2007, 7:1542-1550.
18. Costa M., Mollenhauer H.H. Carcinogenic activity of particulate nickel compounds is proportional to their cellular uptake. Science 1980, 209:515-517.
19. Costa M., Mollenhauer H.H. Phagocytosis of nickel subsulfide particles during the early stages of neoplastic transformation in tissue-culture. Cancer Res. 1980, 40:2688-2694.
20. Costa M., Mollenhauer H.H. Phagocytosis of particulate nickel compounds is related to their carcinogenic activity. Ann. Clin. Lab. Sci. 1981, 11:175-185.
21. Costa M., Nye J., Sunderman F.W.J. Morphological transformation of syrian hamster fetal cells induced by nickel compounds. Ann. Clin. Lab. Sci. 1978, 8:502.
22. Costa M., Nye J.S., Sunderman F.W., Allpass P.R., Gondos B. Induction of sarcomas in nude-mice by implantation of syrian-hamster fetal cells exposed invitro to nickel subsulfide. Cancer Res. 1979, 39:3591-3597.
23. Costa M., Mollenhauer H.H., Jones M.K. Carcinogenic activity of nickel compounds may be related to their cellular uptake. Fed. Proc. 1980, 39:515-517.
24. Costa M., Abbracchio M.P., Simmonshansen J. Factors influencing the phagocytosis, neoplastic transformation, and cyto-toxicity of particulate nickel compounds in tissue-culture systems. Toxicol. Appl. Pharmacol. 1981, 60:313-323.
25. Costa M., Simmonshansen J., Bedrossian C.W.M., Bonura J., Caprioli R.M. Phagocytosis, cellular-distribution, and carcinogenic activity of particulate nickel compounds in tissue-culture. Cancer Res. 1981, 41:2868-2876.
26. Costa M., Heck J.D., Robison S.H. Selective phagocytosis of crystalline metal sulfide particles and dna strand breaks as a mechanism for the induction of cellular-transformation. Cancer Res. 1982, 42:2757-2763.
27. Davidson T., Chen H.B., Garrick M.D., D'Angelo G., Costa M. Soluble nickel interferes with cellular iron homeostasis. Mol. Cell. Biochem. 2005, 279:157-162.
28. Davidson T.L., Chen H., Di Toro D.M., D'Angelo G., Costa M. Soluble nickel inhibits HIF-prolyl-hydroxylases creating persistent hypoxic signaling in A549 cells. Mol. Carcinog. 2006, 45:479-489.
29. Denkhaus E., Salnikow K. Nickel essentiality, toxicity, and carcinogenicity. Crit. Rev. Oncol. Hematol. 2002, 42:35-56.
30. Dharmawardhane S., Schurmann A., Sells M.A., Chernoff J., Schmid S.L., Bokoch G.M. Regulation of macropinocytosis by p21-activated kinase-1. Mol. Biol. Cell 2000, 11:3341-3352.
31. Dipaolo J.A., Casto B.C. Quantitative studies of invitro morphological transformation of syrian-hamster cells by inorganic metal-salts. Cancer Res. 1979, 39:1008-1013.
32. Doll R., Morgan L.G. Cancers of lung and nasal sinuses in nickel workers. Br. J. Cancer 1970, 24:623-632.
33. Doll R., Mathews J.D., Morgan L.G. Cancers of lung and nasal sinuses in nickel workers - reassessment of period of risk. Br. J. Ind. Med. 1977, 34:102-105.
34. Doll R., Andersen A., Cooper W.C., Cosmatos I., Cragle D.L., Easton D., Enterline P., Goldberg M., Metcalfe L., Norseth T., Peto J., Rigaut J.P., Roberts R., Seilkop S.K., Shannon H., Speizer F., Sunderman F.W., Thornhill P., Warner J.S., Weglo J., Wright M. Report of the international-committee-on-nickel-carcinogenesis-in-man. Scand. J. Work. Environ. Heal. 1990, 16:1-82.
35. Duda-Chodak A., Blaszczyk U. The impact of nickel on human health. J. Elem. 2008, 13:685-696.
36. Dunnick J.K., Elwell M.R., Radovsky A.E., Benson J.M., Hahn F.F., Nikula K.J., Barr E.B., Hobbs C.H. Comparative carcinogenic effects of nickel subsulfide, nickel-oxide, or nickel sulfate hexahydrate chronic exposures in the lung. Cancer Res. 1995, 55:5251-5256.
37. Evans R.M., Davies P.J.A., Costa M. Video time-lapse microscopy of phagocytosis and intracellular fate of crystalline nickel sulfide particles in cultured mammalian-cells. Cancer Res. 1982, 42:2729-2735.
38. Falcone S., Cocucci E., Podini P., Kirchhausen T., Clementi E., Meldolesi J. Macropinocytosis: regulated coordination of endocytic and exocytic membrane traffic events. J. Cell Sci. 2006, 119:4758-4769.
39. Feinberg A.P., Oshimura M., Barrett J.C. Epigenetic mechanisms in human disease. Cancer Res. 2002, 62:6784-6787.
40. Flyvholm M.A., Nielsen G.D., Andersen A. Nickel content of food and estimation of dietary-intake. Z. Lebensm. Unters. Forsch. 1984, 179:427-437.
41. Fragou D., Fragou A., Kouidou S., Njau S., Kovatsi L. Epigenetic mechanisms in metal toxicity. Toxicol. Mech. Methods 2011, 21:343-352.
42. Funakoshi T., Inoue T., Shimada H., Kojima S. The mechanisms of nickel uptake by rat primary hepatocyte cultures: role of calcium channels. Toxicology 1997, 124:21-26.
43. Gillespie P.A., Kang G.S., Elder A., Gelein R., Chen L., Moreira A.L., Koberstein J., Tchou-Wong K.M., Gordon T., Chen L.C. Pulmonary response after exposure to inhaled nickel hydroxide nanoparticles: short and long-term studies in mice. Nanotoxicology 2010, 4:106-119.
44. Goodman J.E., Prueitt R.L., Dodge D.G., Thakali S. Carcinogenicity assessment of water-soluble nickel compounds. Crit. Rev. Toxicol. 2009, 39:365-417.
45. Goodman J.E., Prueitt R.L., Thakali S., Oller A.R. The nickel ion bioavailability model of the carcinogenic potential of nickel-containing substances in the lung. Crit. Rev. Toxicol. 2011, 41:142-174.
46. Govindarajan B., Klafter R., Miller M.S., Mansur C., Mizesko M., Bai X.H., LaMontagne K., Arbiser J.L. Reactive oxygen-induced carcinogenesis causes hypermethylation of p16(Ink4a) and activation of MAP kinase. Mol. Med. 2002, 8:1-8.
47. Gregory C.D. CD14-dependent clearance of apoptotic cells: relevance to the immune system. Curr. Opin. Immunol. 2000, 12:27-34.
48. Griffitt R.J., Luo J., Gao J., Bonzongo J.C., Barber D.S. Effects of particle composition and species on toxicity of metallic nanomaterials in aquatic organisms. Environ. Toxicol. Chem. 2008, 27:1972-1978.
49. Guo D.D., Wu C.H., Li X.M., Jiang H., Wang X.M., Chen B.A. In vitro cellular uptake and cytotoxic effect of functionalized nickel nanoparticles on leukemia cancer cells. J. Nanosci. Nanotechnol. 2008, 8:2301-2307.
50. Heck J.D., Costa M. Extracellular requirements for the endocytosis of carcinogenic crystalline nickel sulfide particles by facultative phagocytes. Toxicol. Lett. 1982, 12:243-250.
51. Heck J.D., Costa M. Surface reduction of amorphous nis particles potentiates their phagocytosis and subsequent induction of morphological transformation in syrian-hamster embryo cells. Cancer Lett. 1982, 15:19-26.
52. Herlantpeers M.C., Hildebrand H.F., Kerckaert J.P. Invitro and invivo incorporation of Ni-63 ii into lung and liver subcellular-fractions of balb/c mice. Carcinogenesis 1983, 4:387-392.
53. Horak E., Sunderman F.W. Fecal nickel excretion by healthy adults. Clin. Chem. 1973, 19:429-430.
54. Horie M., Nishio K., Fujita K., Kato H., Nakamura A., Kinugasa S., Endoh S., Miyauchi A., Yamamoto K., Mrayama H., Niki E., Iwahashi H., Yoshida Y., Nakanishi J. Ultrafine NiO particles induce cytotoxicity in vitro by cellular uptake and subsequent Ni(II) release. Chem. Res. Toxicol. 2009, 22:1415-1426.
55. Huang X., Klein C.B., Costa M. Crystalline ni3s2 specifically enhances the formation of oxidants in the nuclei of cho cells as detected by dichlorofluorescein. Carcinogenesis 1994, 15:545-548.
56. Huang X., Zhuang Z.X., Frenkel K., Klein C.B., Costa M. The role of nickel and nickel-mediated reactive oxygen species in the mechanism of nickel carcinogenesis. Environ. Heal. Perspect. 1994, 102:281-284.
57. Ispas C., Andreescu D., Patel A., Goia D.V., Andreescu S., Wallace K.N. Toxicity and developmental defects of different sizes and shape nickel nanoparticles in zebrafish. Environ. Sci. Technol. 2009, 43:6349-6356.
58. Ivanov A.I. Pharmacological inhibition of endocytic pathways: is it specific enough to be useful?. Methods Mol. Biol. 2008, 440:15-33.
59. Kaksonen M., Toret C.P., Drubin D.G. Harnessing actin dynamics for clathrin-mediated endocytosis. Nat. Rev. Mol. Cell Biol. 2006, 7:404-414.
60. Kang J., Zhang Y.T., Chen J., Chen H.F., Lin C.J., Wang Q., Ou Y.X. Nickel-induced histone hypoacetylation: the role of reactive oxygen species. Toxicol. Sci. 2003, 74:279-286.
61. Karaczyn A.A., Golebiowski F., Kasprzak K.S. Truncation, deamidation, and oxidation of histone H2B in cells cultured with nickel(II). Chem. Res. Toxicol. 2005, 18:1934-1942.
62. Karaczyn A.A., Golebiowski F., Kasprzak K.S. Ni(II) affects ubiquitination of core histones H2B and H2A. Exp. Cell Res. 2006, 312:3252-3259.
63. Kargacin B., Klein C.B., Costa M. Mutagenic responses of nickel oxides and nickel sulfides in chinese-hamster v79 cell-lines at the xanthine guanine phosphoribosyl transferase locus. Mutat. Res. 1993, 300:63-72.
64. Karlsson H.L., Gustafsson J., Cronholm P., Moller L. Size-dependent toxicity of metal oxide particles - a comparison between nano- and micrometer size. Toxicol. Lett. 2009, 188:112-118.
65. Kasprzak K.S., Hernandez L. Enhancement of hydroxylation and deglycosylation of 2'-deoxyguanosine by carcinogenic nickel compounds. Cancer Res. 1989, 49:5964-5968.
66. Kasprzak K.S., Gabryel P., Jarczewska K. Carcinogenicity of nickel(ii)hydroxides and nickel(ii)sulfate in Wistar rats and its relation to the invitro dissolution rates. Carcinogenesis 1983, 4:275-279.
67. Kasprzak K.S., Quander R.V., Poirier L.A. Effects of calcium and magnesium salts on nickel subsulfide carcinogenicity in fischer rats. Carcinogenesis 1985, 6:1161-1166.
68. Ke Q., Davidson T., Chen H., Kluz T., Costa M. Alterations of histone modifications and transgene silencing by nickel chloride. Carcinogenesis 2006, 27:1481-1488.
69. Keen J.H., Willingham M.C., Pastan I.H. Clathrin-coated vesicles - isolation, dissociation and factor-dependent reassociation of clathrin baskets. Cell 1979, 16:303-312.
70. Klein C.B., Conway K., Wang X.W., Bhamra R.K., Lin X.H., Cohen M.D., Annab L., Barrett J.C., Costa M. Senescence of nickel-transformed cells by an X-chromosome - possible epigenetic control. Science 1991, 251:796-799.
71. Lee Y.W., Klein C.B., Kargacin B., Salnikow K., Kitahara J., Dowjat K., Zhitkovich A., Christie N.T., Costa M. Carcinogenic nickel silences gene-expression by chromatin condensation and dna methylation - a new model for epigenetic carcinogens. Mol. Cell. Biol. 1995, 15:2547-2557.
72. Light W.G., Wei E.T. Surface-charge and hemolytic activity of asbestos. Environ. Res. 1977, 13:135-145.
73. Lippmann M., Ito K., Hwang J.-S., Maciejczyk P., Chen L.-C. Cardiovascular effects of nickel in ambient air. Environ. Heal. Perspect. 2006, 114:1662-1669.
74. Lunov O., Syrovets T., Loos C., Beil J., Delecher M., Tron K., Nienhaus G.U., Musyanovych A., Mailander V., Landfester K., Simmet T. Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line. ACS Nano 2011, 5:1657-1669.
75. Mailander V., Landfester K. Interaction of nanoparticles with cells. Biomacromolecules 2009, 10:2379-2400.
76. May R.C., Machesky L.M. Phagocytosis and the actin cytoskeleton. J. Cell Sci. 2001, 114:1061-1077.
77. Mayer C., Klein R.G., Wesch H., Schmezer P. Nickel subsulfide is genotoxic in vitro but shows no mutagenic potential in respiratory tract tissues of Big Blue (TM) rats and Muta (TM) Mouse mice in vivo after inhalation. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 1998, 420:85-98.
78. M'Bemba-Meka P., Lemieux N., Chakrabarti S.K. Role of oxidative stress, mitochondrial membrane potential, and calcium homeostasis in nickel subsulfide-induced human lymphocyte death in vitro. Sci. Total. Environ. 2006, 369:21-34.
79. McMahon H.T., Boucrot E. Molecular mechanism and physiological functions of clathrin-mediated endocytosis. Nat. Rev. Mol. Cell Biol. 2011, 12:517-533.
80. Meng H., Yang S., Li Z.X., Xia T., Chen J., Ji Z.X., Zhang H.Y., Wang X., Lin S.J., Huang C., Zhou Z.H., Zink J.I., Nel A.E. Aspect ratio determines the quantity of mesoporous silica nanoparticle uptake by a small GTPase-dependent macropinocytosis mechanism. ACS Nano 2011, 5:4434-4447.
81. Mercer J., Helenius A. Virus entry by macropinocytosis. Nat. Cell Biol. 2009, 11:510-520.
82. Migdal C., Rahal R., Rubod A., Callejon S., Colomb E., Atrux-Tallau N., Haftek M., Vincent C., Serres M., Daniele S. Internalisation of hybrid titanium dioxide/para-amino benzoic acid nanoparticles in human dendritic cells did not induce toxicity and changes in their functions. Toxicol. Lett. 2010, 199:34-42.
83. Miura T., Patierno S.R., Sakuramoto T., Landolph J.R. Morphological and neoplastic transformation of C3H-10T1/2 CL-8 mouse embryo cells by insoluble carcinogenic nickel compounds. Environ. Mol. Mutagen. 1989, 14:65-78.
84. Monteiller C., Tran L., MacNee W., Faux S., Jones A., Miller B., Donaldson K. The pro-inflammatory effects of low-toxicity low-solubility particles, nanoparticles and fine particles, on epithelial cells in vitro: the role of surface area. Occup. Environ. Med. 2007, 64:609-615.
85. Nandi P.K., Vanjaarsveld P.P., Lippoldt R.E., Edelhoch H. Effect of basic compounds on the polymerization of clathrin. Biochemistry 1981, 20:6706-6710.
86. Nel A., Xia T., Madler L., Li N. Toxic potential of materials at the nanolevel. Science 2006, 311:622-627.
87. Nel A.E., Madler L., Velegol D., Xia T., Hoek E.M.V., Somasundaran P., Klaessig F., Castranova V., Thompson M. Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 2009, 8:543-557.
88. Nunes P., Demaurex N. The role of calcium signaling in phagocytosis. J. Leukoc. Biol. 2010, 88:57-68.
89. Ohsawa K., Imai Y., Kanazawa H., Sasaki Y., Kohsaka S. Involvement of Iba1 in membrane ruffling and phagocytosis of macrophages/microglia. J. Cell Sci. 2000, 113:3073-3084.
90. Oller A.R., Oberdorster G. Incorporation of particle size differences between animal studies and human workplace aerosols for deriving exposure limit values. Regul. Toxicol. Pharmacol. 2010, 57:181-194.
91. Oller A.R., Costa M., Oberdorster G. Carcinogenicity assessment of selected nickel compounds. Toxicol. Appl. Pharmacol. 1997, 143:152-166.
92. Onkelinx C., Becker J., Sunderman F.W. Compartmental analysis of metabolism of Ni-63(ii) in rats and rabbits. Res. Commun. Chem. Pathol. Pharmacol. 1973, 6:663-676.
93. Oskarsson A., Tjalve H. Autoradiographic study on the distribution of (Ni-63)-CL-2 in mice. Ann. Clin. Lab. Sci. 1979, 9:47-59.
94. Pan J., Chang Q., Wang X., Son Y., Liu J., Zhang Z., Bi Y., Shi X. Activation of Akt/GSK3β and Akt/Bcl-2 signaling pathways in nickel-transformed BEAS-2B cells. Int. J. Oncol. 2011, 39:1285-1294.
95. Panicker A.K., Buhusi M., Erickson A., Maness P.F. Endocytosis of beta 1 integrins is an early event in migration promoted by the cell adhesion molecule L1. Exp. Cell Res. 2006, 312:299-307.
96. Patierno S.R., Dirscherl L.A., Xu J. Transformation of rat tracheal epithelial-cells to immortal growth variants by particulate and soluble nickel compounds. Mutat. Res. 1993, 300:179-193.
97. Petros R.A., DeSimone J.M. Strategies in the design of nanoparticles for therapeutic applications. Nat. Rev. Drug Discovery 2010, 9:615-627.
98. Phillips J.I., Green F.Y., Davies J.C.A., Murray J. Pulmonary and systemic toxicity following exposure to nickel nanoparticles. Am. J. Ind. Med. 2010, 53:763-767.
99. Pott F., Rippe R.M., Roller M., Csicsaky M., Rosenbruch M., Huth F. Carcinogenicity of nickel compounds and nickel alloys in rats by I.P. injection. Nickel and Human Health: Current Perspectives 1992, 491-502. John Wiley and Sons, New York. E. Nieboer, J.O. Nriagu (Eds.).
100. Rauch J.N., Pacyna J.M. Earth's global Ag, Al, Cr, Cu, Fe, Ni, Pb, and Zn cycles. Global Biogeochem. Cycle 2009, 23:16.
101. Refsvik T., Andreassen T. Surface binding and uptake of nickel(ii) in human epithelial kidney-cells - modulation by ionomycin, nicardipine and metals. Carcinogenesis 1995, 16:1107-1112.
102. Rodriguez R.E., Misra M., Diwan B.A., Riggs C.W., Kasprzak K.S. Relative susceptibilities of C57BL/6, (C57BL/6xC3H/He)F-1, and C3H/He mice to acute toxicity and carcinogenicity of nickel subsulfide. Toxicology 1996, 107:131-140.
103. Salnikow K., Zhitkovich A. Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: nickel, arsenic, and chromium. Chem. Res. Toxicol. 2008, 21:28-44.
104. Sarkar K., Kruhlak M.J., Erlandsen S.L., Shaw S. Selective inhibition by rottlerin of macropinocytosis in monocyte-derived dendritic cells. Immunology 2005, 116:513-524.
105. Shaw B.J., Handy R.D. Physiological effects of nanoparticles on fish: a comparison of nanometals versus metal ions. Environ. Int. 2011, 37:1083-1097.
106. Sunderman F.W., Selin C.E. Metabolism of nickel-63 carbonyl. Toxicol. Appl. Pharmacol. 1968, 12:207-212.
107. Sunderman F.W. Review of carcinogenicities of nickel, chromium and arsenic compounds in man and animals. Prev. Med. 1976, 5:279-294.
108. Sunderman F.W. Carcinogenic effects of metals. Fed. Proc. 1978, 37:40-46.
109. Sunderman F.W., Maenza R.M. Comparisons of carcinogenicities of nickel compounds in rats. Res. Commun. Chem. Pathol. Pharmacol. 1976, 14:319-330.
110. Suzuki Y. Interaction of asbestos with alveolar cells. Environ. Heal. Perspect. 1974, 9:241-252.
111. Thurn K.T., Arora H., Paunesku T., Wu A.G., Brown E.M.B., Doty C., Kremer J., Woloschak G. Endocytosis of titanium dioxide nanoparticles in prostate cancer PC-3M cells. Nanomed. Nanotechnol. Biol. Med. 2011, 7:123-130.
112. Underhill D.M., Ozinsky A. Phagocytosis of microbes: complexity in action. Annu. Rev. Immunol. 2002, 20:825-852.
113. Vincent J.H., Ramachandran G., Kerr S.M. Particle size and chemical species 'fingerprinting' of aerosols in primary nickel production industry workplaces. J. Environ. Monit. 2001, 3:565-574.
114. Waalkes M.P., Liu J., Kasprzak K.S., Diwan B.A. Metallothionein-I/II double knockout mice are no more sensitive to the carcinogenic effects of nickel subsulfide than wild-type mice. Int. J. Toxicol. 2005, 24:215-220.
115. Warheit D.B. Debunking some misconceptions about nanotoxicology. Nano Lett. 2010, 10:4777-4782.
116. Warheit D.B., Webb T.R., Sayes C.M., Colvin V.L., Reed K.L. Pulmonary instillation studies with nanoscale TiO2 rods and dots in rats: toxicity is not dependent upon particle size and surface area. Toxicol. Sci. 2006, 91:227-236.
117. Warheit D.B., Webb T.R., Colvin V.L., Reed K.L., Sayes C.R. Pulmonary bioassay studies with nanoscale and fine-quartz particles in rats: toxicity is not dependent upon particle size but on surface characteristics. Toxicol. Sci. 2007, 95:270-280.
118. Zhao J.S., Shi X.L., Castranova V., Ding M. Occupational toxicology of nickel and nickel compounds. J. Environ. Pathol. Toxicol. Oncol. 2009, 28:177-208.
119. Zhao F., Zhao Y., Liu Y., Chang X.L., Chen C.Y., Zhao Y.L. Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. Small 2011, 7:1322-1337.
120. Zoroddu M.A., Peana M., Medici S., Casella L., Monzani E., Costa M. Nickel binding to histone H4. Dalton Trans. 2010, 39:787-793.